According to the 'hygiene hypothesis', enhanced microbial exposure due to early childhood infections leads to a reduction of T h 2-mediated allergic diseases and inflammatory bowel disease. To begin to elucidate the mechanisms underlying this hypothesis, we studied development of T h 2-mediated colitis of the TCRa knockout (KO) mouse in both a specific pathogen-free (SPF) facility and a conventional (CV) facility. After more than five generations in each facility, TCRa KO mice kept in the CV facility developed dramatically less colitis than mice that were kept in the SPF facility. Surprisingly, the suppression of colitis in the CV facility correlated with a significant increase in natural IgM production by B-1 B cells. In contrast, B cell-deficient TCRa double-knockout (am DKO) mice maintained in the CV facility continued to develop severe colitis, strongly suggesting that B-1 B cells contributed to the suppression of colitis. Indeed, the adoptive transfer of B-1 B cells isolated from the peritoneal cavity of TCRa KO mice (SPF) into am DKO mice (CV) suppressed the development of colitis in the recipient mice. We conclude that B-1 cells play a regulatory role in T h 2-mediated colitis under non-hygienic conditions, possibly by generating natural antibodies in response to microbial flora.
Introduction
The 'hygiene hypothesis' is the concept that the frequent use of antibiotics and improved sanitary conditions in the industrialized countries has led to decreased childhood infections and increased susceptibility to T h 2-mediated allergic diseases such as asthma and atopic dermatitis (1) (2) (3) . The hygiene hypothesis may also explain the association of inflammatory bowel disease (IBD) and autoimmunity with modern living conditions (4, 5) . However, the immunological mechanisms involved in the hygiene hypothesis have not been fully defined.
Since the mucosal immune system is constantly exposed to a variety of microbial antigens in the intestinal lumen, it is essential that there is development of tolerance to enteric commensal flora without compromising the ability to effectively respond to infectious microbes. Dysregulation of immune response to normal enteric flora leads to the development of colitis (6) (7) (8) (9) . Recent studies indicate that bacterial products contribute to the suppression of colitis by activating innate immune responses that are required for the preservation of intestinal homeostasis (10, 11) . Beneficial effects of certain bacteria (probiotics) on IBD support the significance of relative balance between protective and aggressive micro-organisms in the pathogenesis of this disease (12, 13) . The role of micro-organisms in the colitis pathogenesis may vary depending on the phase and the type of colitis as well as the genetic background (14, 15) .
Chronic colitis in TCRa knockout (KO) is mediated by an IL-4-dependent T h 2 pathway and shares some features with human ulcerative colitis (UC) (6, 16, 17) . In contrast, IL-23/ IL-17 pathway has recently been demonstrated to cause chronic colitis resembling human Crohn's disease (CD) (18) (19) (20) . Both T h 2-mediated colitis in TCRa KO and T h 17-mediated colitis in IL-10 KO mice (19, 20) spontaneously develop in specific pathogen-free (SPF) facilities but not when maintained under germ-free conditions (6, 21) . Although IL-10 KO mice maintained in non-hygienic conventional (CV) facilities develop a colitis of greater severity than those maintained in SPF conditions (21) , TCRa KO mice maintained in CV facilities do not develop colitis (22) . The mechanism by which non-hygienic conditions contribute to the suppression of this colitis was not determined.
In the present study, colitis development was suppressed when TCRa KO mice were maintained for five generations under CV facilities that are less hygienic as compared with SPF conditions. The suppression of colitis required the presence of B cells, which was associated with increased levels of IgM natural antibodies. Since the unique B cell population of B-1 cells that reside primarily in the peritoneal cavity (PerC) are a major source of IgM natural antibodies and participate in the early immune responses against many bacteria and viruses (23), we hypothesized that this subset of B cells may be involved in the suppression of colitis in CV facilities. The transfer of PerC B-1 cells into B cell-deficient TCRa double-knockout (al DKO) mice under CV conditions resulted in the suppression of colitis and the production of IgM antibodies in the spleen with presence in the sera. These results indicate that PerC B-1 cells play a regulatory role in T h 2-mediated colitis under non-hygienic conditions.
Methods

Mice
TCRa KO and Igl (Igh6) KO mice of C57BL/6 (H-2b) background were crossed to generate the al DKO mice (24) . The litters from TCRa KO and al DKO breeding pairs of SPF were either maintained under the SPF or moved to CV facility. After continuous generations of a family lines from the CV first TCRa KO and al DKO mice at the CV facility, the fifth generation of mice were used as CV mice. The CV mice were maintained in cages without filtered lid in a room without negative pressure and drinking water and food without autoclaving was supplied to the mice. Pathogenic bacteria, worm or parasites were not detectable in the CV mice and serological test against pathogenic viruses such as murine hepatitis virus was negative in these mice.
Histological examination
Specimens of colon were fixed in 10% buffered formalin and stained with hematoxylin and eosin. The severity of colitis was determined using a combination of gross and histological criteria as previously described (25, 26) . The gross score was rated as 0, presence of normal beaded appearance; 1, absence of beaded appearance of colon; 2, focal thickened colon and 3, marked thickness of the entire colon. The histological score was based upon the extent of intestinal wall thickening (0-3) and lamina propria cell infiltration (0-3). The disease score (0-9) was estimated by the addition of both gross and histological findings.
Cell preparation
Peyer's patches (PP), cecal patches/appendix lymphoid follicles (ALF) and mesenteric lymph node (MLN) cells were extracted as described previously (27) . For purification of B cells, the cells were incubated with PE-conjugated anti-Igl (Caltag/Invitrogen, Carlsbad, CA, USA) at 4°C for 30 min, and then incubated with the anti-PE microbeads at 4°C for 30 min. After washing, the labeled cells were subjected to MACS system (Miltenyi Biotec Inc., Auburn, CA, USA).
Cell transfer
CD11b
+ B-1 B cells were purified from the PerC TCRa KO mice. The peritoneal cells were collected using a modification of a previously described method (28) . Briefly, a PerC lavage was carried out by flushing the PerC with 8 ml of sterile PBS. The PerC lavage cells were plated in tissue culture dish (Falcon 3802) for 2 h at 37°C, 5% CO 2 to remove macrophages; the non-adherence cells were collected and erythrocytes were removed. CD11b + B-1 B cells were purified using FITC-anti-CD11b (M1/70) (BioLegend, San Diego, CA USA) and MACS system (Miltenyi Biotec Inc.); 2-5 3 10 5 purified cells or PBS (as a control) were injected intra-peritoneally into 1-month-old al DKO mice maintained in the CV facilities. The al DKO mice transferred with B-1 B cells or injected with PBS were sacrificed at 6 months of age for the presence of colitis.
Flow cytometry
Cells from the spleen and PerC were stained with labeled anti-mouse FITC-CD11b (M1/70) (BioLegend), PE-conjugated anti-Igl (Caltag/Invitrogen) and PerCP-B220 (RA3-6B2) (BD Bioscience, San Jose, CA, USA). Data analyzed with CellQuest.
Fecal pellet collection
Fresh fecal pellets were collected as described previously (29) and weighed. PBS containing protease inhibitor was added in the ratio of 1 ml per 100 mg fecal pellets and the mixture incubated for 15 min at room temperature. Samples were vortexed, left to settle for 15 min and re-vortexed until all material was suspended. The tubes were centrifuged at 3000 3 g for 15 min at 4°C and the supernatant stored at À70°C till assayed.
ELISPOT assay
Enzyme-linked immune spot (ELISPOT) assay was performed as described previously (27) . A 96-well plate with a nitrocellulose base (Millititer HA; Millipore Corporation, Bedford, MA, USA) was coated overnight at 4°C with 100 m1 of goat anti-mouse Ig (5 mg ml
À1
; Dako, Glostrup, Denmark) in D-PBS. After wash, the wells were blocked with 3% BSA/ PBS at 37°C for 1 h. Cells (1 3 l0 5 to 5 3 10 2 cells per well) in 100 ml of Iscove's modified Dulbecco's medium complete medium containing 10% FCS were added to each well and incubated at 37°C for 16 h. Following subsequent washes with PBS, water, 0.25% Tween/PBS and 0.05% Tween/PBS, the wells were re-blocked with 3% BSA/2% goat serum/PBS for 1 h. The wells were washed again and incubated with HRP antibodies specific to Ig isotypes (IgM, IgA and IgG) (Serotec, Raleigh, NC, USA; Southern Biotechnology, Birmingham, AL, USA) in 0.5% BSA/0.05% Tween/PBS overnight at 4°C. The wells were washed and developed with 3-amino-9-ethyl carbazole. The reaction was stopped by a wash with tap water.
ELISA for detection of antigen-specific-binding Ig
A 96-well plate (Polysorb, Nunc; Thermo Fisher Scientific Inc., Waltham, MA, USA) was coated 100 ll per well with 10 lg ml À1 phosphoryl choline (PC)-BSA (Biosearch Technologies Inc., Novato, CA, USA) in coating buffer (Na 2 CO 3 / NaHCO 3 , pH 9.4) overnight at 4°C, then incubated with blocking buffer (0 05% Tween 20 and 0-25% gelatin in PBS) for 30 min at room temperature and then washed twice with distilled water. Sera or fecal pellet supernatants were diluted 1/10 in blocking buffer, 50 ll added to the plates and then incubated for 1 h at room temperature. Plate was then washed in PBS containing 0 05% Tween 20 and 50 ll per well of HRP-conjugated goat anti-mouse IgA or anti-mouse IgM (Serotec) was diluted 1/2000 in blocking buffer and 50 ll was added to corresponding wells for 1 h. After a further wash, 100 ll of substrate solution [prepared by mixing equal volumes of substrate A and B (BD Bioscience)] was added to the plate, incubated for 30 min at room temperature, followed by addition of 50 ll of 1 M ortho-phosphoric acid stop solution to each well. The plate was read at 405 nm using a BioRad 680 ELISA plate reader and results were statistically analyzed using Mann-Whitney U-test.
Results
Non-hygienic environment suppresses development of colitis in TCRa KO mice
Young TCRa KO mice that had been housed in SPF facility were transferred to CV facility to determine if the less Fig. 1 . Suppression of colitis under CV conditions. The litters from TCRa KO breeding pairs from SPF facility were either maintained under the SPF conditions or moved to CV facility (CV-1st). The CV first TCRa KO mice were maintained for more than five generations at the CV facility. The SPF, CV first and fifth generation CV TCRa KO mice (CV) were sacrificed at 6 months of age and the disease severity evaluated by a combination of gross and histological examinations. hygienic conditions present in CV facility would have an effect on the development of colitis. The majority of CV first TCRa KO mice, which were directly transferred from SPF to CV facility, continued to develop colitis (Fig. 1c) . However, the incidence of colitis development decreased gradually during the subsequent generations of mice in the CV facility. The fifth generation of TCRa KO mice bred in the CV facility exhibited a significant decrease in the incidence and severity of colitis as compared with SPF TCRa KO mice (Fig. 1a-c) . These findings suggest that continuous exposure to incompletely sanitized environment of CV facility over several generations is needed to fully suppress colitis development in TCRa KO mice, maintained previously in SPF conditions.
We next performed terminal restriction fragment-length polymorphism (T-RFLP) analysis using the luminal contents and intestinal tissues from the distal part of the small intestine, cecum and distal part of the large intestine to determine the effect of CV facility on the bacterial diversity. Although T-RFLP is a powerful approach for the assessment of diversity of bacterial flora (30), we did not find any major differences in the bacterial colonization in the colon of CV TCRa KO mice as compared with SPF TCRa KO mice (data not shown).
B cells are required for the suppression of the colitis development in TCRa KO mice under CV conditions Since our previous studies clearly indicate that B cells regulate the colitis of TCRa KO mice (24, 31), we investigated the possibility that B cell-related immune mechanisms play a role in the suppression of colitis observed in CV environment. We next evaluated the development of colitis in al DKO mice maintained in CV facility for more than five generations. As previously described (24) , the severity of colitis in SPF al DKO mice was markedly more than in SPF TCRa KO mice (Figs 1c and 2b) . Interestingly, like SPF al DKO mice, the CV al DKO mice continued to develop severe colitis as judged by thickening of colonic wall, elongation of crypts and diffuse inflammatory cell infiltration. There was no statistically significant difference in the incidence and severity of colitis between CV al DKO mice and SPF al DKO mice (Fig. 2) . These results indicate that suppression of colitis in TCRa KO mice under CV environment does not occur in the absence of B cells.
B cells are activated under CV conditions
To determine whether activation of B cells occurs under CV environment, phenotypic and functional characteristics of B cells from different tissues including spleen, colon and gut-associated lymphoid tissues (GALT), such as ALF, PP and MLNs, of CV TCRa KO mice were compared with B cells from SPF TCRa KO mice. ELISPOT assay for the detection of spontaneous Igs production showed that IgA and IgM productions by splenic B cells was significantly upregulated in the CV TCRa KO mice compared with SPF TCRa KO mice (Fig. 3a and b and data not shown) . These findings suggest that B cells are significantly and constitutively activated under CV conditions.
Since our previous experiments have identified an IL-10-producing B cell subset that is involved in the attenuation of ongoing colitis in TCRa KO mice maintained in SPF facilities (24, 31, 32) , B cells from the GALT and colonic lamina propria were evaluated for IL-10 production. There was no difference in the level of IL-10 production by between B cells from CV TCRa KO mice and SPF TCRa KO mice (data not shown).
CV conditions activate B-1 B cells
B-1 cells are well known to participate in the early phases of immune response against bacteria (23) and characteristically produce natural IgM antibodies (23, 33, 34) . Since IgM production by the splenic B cells was significantly enhanced under the CV condition, we next assessed the effect of CV conditions on B1 cells. Interestingly, the proportion of B-1 B cells in the PerC was increased in the CV TCRa KO mice compared with the SPF TCRa KO mice ( Fig. 4a and b) . However, there were no differences between the number of PerC CD5
+ B-1a cells in the SPF and CV TCRa KO mice, suggesting an increase in the CD5 À B-1b but not CD5 + B1a cells under CV (data not shown).
Natural antibodies produced by B1 cells react with ubiquitous bacterial antigens such as PC (34) . Therefore, the production of the IgA and IgM antibodies specific for PC was evaluated. Anti-PC IgM antibodies were significantly increased in the sera of CV TCRa KO mice as compared with SPF TCRa KO mice, whereas there was no significant difference in the production of anti-PC IgA antibodies among these mice groups (Fig. 4c) . Since the amount of anti-PC antibody in the fecal pellets corresponds with the number of host B-1 B cells (28) , the amount of IgA and IgM antibodies specific for PC in the fecal pellets was measured. Anti-PC IgM but not IgA antibodies were significantly increased in the fecal pellets from CV TCRa KO mice as compared with SPF TCRa KO mice (Fig. 4d) .
B-1 B cells contribute to the inhibition of colitis under CV conditions
The presence of significantly activated B-1 B cells in the CV TCRa KO mice raised the possibility that B-1 B cells may be involved in the suppression of colitis in CV TCRa KO mice. Since B1 B cells are preferentially located in the PerC and are the major source of natural antibodies, PerC B-1 B cells from SPF TCRa KO mice were adoptively transferred into B cell-deficient CV al DKO mice at 1 month of age and the recipient mice were then sacrificed at 6 months of age. Interestingly, the reconstitution of B-1 B cells in CV al DKO mice resulted in significant suppression of colitis in the recipient al DKO mice ( Fig. 5a and b) . Flow cytometric analysis confirmed reconstitution of donor-derived IgM + CD11b + B-1 B cells in the PerC of the recipient al DKO mice. These reconstituted B-1 B cells did not express CD5 (Fig. 5c) . Of note, IgM-producing cells were detectable in the spleen of recipient al DKO mice following B-1 B cell reconstitution (Fig. 5d) . The reconstitution of B-1 B cells in the recipient al DKO mice was also associated with an increase in the serum IgM specific for PC (Fig. 5e) . These findings indicate that B-1 B cells regulate colitis and produce natural IgM antibodies under CV conditions.
Discussion
The increased incidence of IBD in the last several decades has been associated with an improvement in living conditions (4, 5) . Although in the Western countries, the hygiene hypothesis has been considered to play a role in the pathogenesis of human CD but not UC (4, 5), the incidence of UC but not CD has continued to increase in Asian countries (Japan and Korea) as the sanitary conditions have improved during the last two decades (35) . It is likely that the effect of hygienic conditions on CD pathogenesis in the Western population is influenced by genetic susceptibility as an association of IBD development with the variants in major IBDsusceptible genes (NOD2, autophagy-related 16-like 1 and IL-23) has been observed in the Western population, but not in the Japanese population (36) . The differences in the criteria used for the evaluation of sanitized conditions (4) may have also influenced results of these epidemiological studies. The experimental models of IBD have helped dissect the different components of chronic intestinal inflammation (6, 37, 38) . Many of these experimental models are T h 1 mediated and are considered to resemble CD. The T h 2-mediated colitis model in TCRa KO mice shares some features with human UC including restriction of inflammation to the colon, presence of circulating autoantibodies and the protective role of appendectomy in the development of colitis (6, 16, 17) . Interestingly, the T h 1-mediated colitis in IL-10 KO mice (21) is exacerbated under CV conditions. In contrast, we demonstrate here that the CV environment suppresses the T h 2-mediated colonic inflammation in the TCRa KO mice.
In our study, the TCRa KO from SPF facilities had to be maintained for five generation in CV facilities to fully observe the suppressive effect of the CV environment on colitis development (Fig. 1) . This may reflect the time taken for the mice to be colonized completely by the microbial flora of CV environment as in the previous report that used embryo transfer technique to re-derive mice for breeding under CV (22) and the suppression of colitis occurred in the first generation of mice (19) . The T-RFLP analysis, which is a powerful approach for the assessment of diversity of bacterial flora (30), showed no major differences in the bacterial colonization in the intestinal luminal contents and intestinal tissues between TCRa KO mice maintained in SPF versus CV facilities. A more detailed quantification of microbial burden as well as differences in the colonization of all microbes including fungi and viruses may be required to demonstrate the effect of hygiene on the microbial diversity in the intestine.
Our previous experiments have established that B cells play an important regulatory role in the suppression of colitis in TCRa KO mice maintained in SPF facilities (24, 31, 32) . A regulatory B cell subset termed 'Breg' (31) that produces IL-10 has been implicated in the attenuation of inflammation not only in TCRa KO mice but also in several other inflammatory conditions including experimental allergic encephalomyelitis and experimental arthritis (31, 39) . However, the IL-10-producing B cell subset in the GALT was not increased in the CV TCRa KO mice as compared with the SPF TCRa KO mice (our unpublished data). Furthermore, the IL-10-producing B cell subset is involved in the amelioration of ongoing colitis but not in the suppression of colitis development (27) . Therefore, we considered the possibility that a different B cell population is involved in the suppression of colitis development under CV environment. The enhanced production of natural IgM capable of binding to PC (Fig. 4a and b) under CV conditions indicated that activation of B-1 B cells, particularly B-1b subset, is involved in the production of natural antibodies and are known to participate in the initial phase of T-independent microbial immune responses (23, 33) . The IgM-producing B cells were detected preferentially in the spleen (Fig. 3a) . This finding is consistent with a recent report that the activation of B-1 B cells induces their mobilization from PerC to the spleen (33) . Since proportionately the number of B-1 B cells in the spleen is very low and it is difficult to obtain a pure population of BI cells without significant contamination by other splenic cells, in particular B2 cells, we decided to use peritoneal B1 cells for the transfer studies. The transfer of B-1 B cells to CV B cell-deficient al DKO led to the inhibition of colitis (Fig. 5a and b) , indicating a regulatory function of this B cell subset. Interestingly, B-1 B cells show a stronger regulatory gene expression signature than CD4 + CD25 + regulatory T cells (40) . Since B-1 B cells have also been reported to be involved in the development of several autoimmune diseases including systemic lupus erythematosus (41) and autoimmune hemolytic anemia (42) , the functional (pathogenic versus regulatory) role of B-1 B cell population may depend on the disease pathogenesis. It is likely that activated B-1 B cells mediate suppression through production of natural IgM antibodies. However, it is technically difficult to purify adequate quantities of natural IgM antibodies for transfer studies to demonstrate suppression of colitis. Since we did not perform B-2 cell transfer studies, we cannot exclude a role of B-2 B cells in the suppression of colitis observed in CV facilities. This study provides a novel insight into the regulatory role of B-1 B cells in environmentally induced suppression of colitis. In contrast to the previously described regulatory B cell subsets that produce IL-10 or IL-12 (24, 31, 32) and regulate ongoing chronic colitis, B-1 B cells prevent the development of colitis. Furthermore, IL-10-and IL-12-producing regulatory B cell subsets are generated during chronic intestinal inflammation, whereas regulatory B-1 B cells are induced without intestinal inflammation under non-hygienic conditions. 
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